-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Oscar Health, Raises Price Target to $33

Benzinga·09/17/2026 12:09:54
Listen to the news
Baird analyst Michael Ha maintains Oscar Health (NYSE:OSCR) with a Neutral and raises the price target from $27 to $33.